中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
20期
3-4,7
,共3页
阿尔茨海默病性痴呆%综合治疗%社区
阿爾茨海默病性癡呆%綜閤治療%社區
아이자해묵병성치태%종합치료%사구
Dementia in Alzheimer's disease%Comprehensive treatment%Community
目的：分析社区中重度阿尔茨海默病性痴呆患者治疗效果。方法对13例筛选出的社区中重度阿尔茨海默病性痴呆患者进行综合治疗，在综合治疗前及治疗后的3个月、6个月分别用修正长谷川痴呆量表、日常生活活动能力评定量表、简明蒙特利尔认知评估量表等进行测评，比较治疗效果。结果日常生活能力量表治疗6个月后为（25.37±4.67），差异有统计学意义，P<0.05；MoCA量表仅命名、语言、定向力三个方面治疗评分较治疗前有所升高，分别为（2.20±0.71）、（1.27±0.41）、（3.89±0.91），差异有统计学意义，P<0.05，其他的四个方面者及HDS-R治疗后的评分与治疗前差异无统计学意义，P>0.05。结论阿尔茨海默病性痴呆临床治疗很难取得令人满意的效果，重在早期预防及仅有轻度认知功能障碍阶段开展干预。
目的：分析社區中重度阿爾茨海默病性癡呆患者治療效果。方法對13例篩選齣的社區中重度阿爾茨海默病性癡呆患者進行綜閤治療，在綜閤治療前及治療後的3箇月、6箇月分彆用脩正長穀川癡呆量錶、日常生活活動能力評定量錶、簡明矇特利爾認知評估量錶等進行測評，比較治療效果。結果日常生活能力量錶治療6箇月後為（25.37±4.67），差異有統計學意義，P<0.05；MoCA量錶僅命名、語言、定嚮力三箇方麵治療評分較治療前有所升高，分彆為（2.20±0.71）、（1.27±0.41）、（3.89±0.91），差異有統計學意義，P<0.05，其他的四箇方麵者及HDS-R治療後的評分與治療前差異無統計學意義，P>0.05。結論阿爾茨海默病性癡呆臨床治療很難取得令人滿意的效果，重在早期預防及僅有輕度認知功能障礙階段開展榦預。
목적：분석사구중중도아이자해묵병성치태환자치료효과。방법대13례사선출적사구중중도아이자해묵병성치태환자진행종합치료，재종합치료전급치료후적3개월、6개월분별용수정장곡천치태량표、일상생활활동능력평정량표、간명몽특리이인지평고량표등진행측평，비교치료효과。결과일상생활능역량표치료6개월후위（25.37±4.67），차이유통계학의의，P<0.05；MoCA량표부명명、어언、정향력삼개방면치료평분교치료전유소승고，분별위（2.20±0.71）、（1.27±0.41）、（3.89±0.91），차이유통계학의의，P<0.05，기타적사개방면자급HDS-R치료후적평분여치료전차이무통계학의의，P>0.05。결론아이자해묵병성치태림상치료흔난취득령인만의적효과，중재조기예방급부유경도인지공능장애계단개전간예。
Objective To analyze the treatment effect of patients with severe dementia in Alzheimer's disease in community. Methods 13 cases of patients with severe dementia in Alzheime's disease in community were selected and given the comprehen-sive treatment. The revised Hasegawa Dementia Scale (HDS-R), Activity of Daily Living Scale (ADL) and Concise Montreal cogni-tive assessment scale(MoCA) were used to evaluate and the efficacy of the patients before treatment and at 3, 6 months after treat-ment was compared, respectively. Results After 6 months of treatment, the Activity of Daily Living Scale was 25.37 ±4.67, the dif-ference was statistically significant compared with that before treatment, P<0.05;in MoCA scale, only the score of the three aspects of name, language, directional force was higher than that of before treatment, respectively, and which was 2.20 ±0.71, 1.27 ±0.41, 3.89 ±0.91, respectively, the differences were statistically significant, P<0.05; the difference in scores of other four aspects and HDS-R after treatment were not significant as compared with those before treatment, P>0.05. Conclusion The clinical treatment of dementia in Alzheimer's disease is very difficult to obtain a satisfactory effect, and more attention should be paid to early preven-tion and the intervention should be carried on at the stage of mild cognitive impairment.
